Sérgio works with different IFPMA regulatory workstreams in the development of technical policy documents and implementation of related advocacy activities for regulatory system strengthening, manufacturing quality, and regulatory reliance.
He also spearheaded IFPMA’s contribution toward the establishment of the Fight the Fakes Alliance.
Before joining IFPMA, Sérgio worked on late-stage drug formulation and development, and as a community pharmacist in Portugal.
Sérgio holds a Diploma in Advanced Studies in Management of Clinical Trials from the University of Geneva and a Master in Pharmaceutical Sciences from the University of Coimbra, Portugal.
Poor-quality care is now a bigger barrier to global health progress than insufficient access to healthcare. This is why policies and regulations that promote delivery of high-quality care and -including high-quality medicines - are so important to IFPMA and its members.
More from Sérgio
What can we learn from how quality and supply of medicinal products were maintained during the COVID-19 pandemic?
The COVID-19 pandemic has had a drastic impact on all the activities related to the development, assessment and approval of medicines and vaccines, unlocking opportunities to work in more agile and collaborative manners. Sérgio Cavalheiro Filho explains what we can learn from this experience when it comes to quality and supply of medicinal products.